Effect of menopausal symptom treatment options on palpitations: a systematic review

References

• North American Menopause Society. Menopause practice: a clinician's guide. 6th ed. Mayfield Heights (OH): North American Menopause Society; 2019.
   Google Scholar
• Islam RM, Bell RJ, Billah B, et al. Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey. Menopause. 2016;23(7):731–739.
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Rizvi F, et al. Vasomotor symptoms in women in Asia appear comparable with women in Western countries: a systematic review. Menopause. 2017;24(11):1313–1322.
   PubMed Web of Science ®Google Scholar
• Minkin MJ, Reiter S, Maamari R. Prevalence of postmenopausal symptoms in North America and Europe. Menopause. 2015;22(11):1231–1238.
   PubMed Web of Science ®Google Scholar
• Sriprasert I, Pantasri T, Piyamongkol W, et al. An International Menopause Society study of vasomotor symptoms in Bangkok and Chiang Mai, Thailand. Climacteric. 2017;20(2):171–177.
   PubMed Web of Science ®Google Scholar
• Obermeyer CM, Reynolds RF, Price K, et al. Therapeutic decisions for menopause: results of the DAMES project in central Massachusetts. Menopause. 2004;11(4):456–465.
   PubMed Web of Science ®Google Scholar
• Nelson HD. Menopause. Lancet. 2008;371(9614):760–770.
   PubMed Web of Science ®Google Scholar
• Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Clin Obstet Gynaecol. 2009;23(1):25–32.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM, Manson JE. Management of menopausal symptoms. Obstet Gynecol. 2015;126(4):859–876.
   PubMed Web of Science ®Google Scholar
• Costanian C, Zangiabadi S, Bahous SA, et al. Reviewing the evidence on vasomotor symptoms: the role of traditional and non-traditional factors. Climacteric. 2020;23(3):213–223.
   PubMed Web of Science ®Google Scholar
• Drewe J, Bucher KA, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus. 2015;4(1):65.
   PubMedGoogle Scholar
• Iliodromiti S, Wang W, Lumsden MA, et al. Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG. 2020;127(3):320–333.
   PubMed Web of Science ®Google Scholar
• Carpenter JS, Sheng Y, Elomba CD, et al. A systematic review of palpitations prevalence by menopausal status. Curr Obstet Gynecol Rep. 2021;10(1):7–13.
   Web of Science ®Google Scholar
• Carpenter JS, Tisdale JE, Chen CX, et al. A menopause Strategies-Finding Lasting Answers for Symptoms and Health (MsFLASH) investigation of self-reported menopausal palpitation distress. J Womens Health (Larchmt). 2021;30(4):533–538.
   PubMed Web of Science ®Google Scholar
• Nyrnes A, Mathiesen EB, Njølstad I, et al. Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromsø Study. Eur J Prev Cardiol. 2013;20(5):729–736.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–847.
   PubMed Web of Science ®Google Scholar
• Pinkerton JV. Money talks: untreated hot flashes cost women, the workplace, and society. Menopause. 2015;22(3):254–255.
   PubMed Web of Science ®Google Scholar
• Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015;22(3):260–266.
   PubMed Web of Science ®Google Scholar
• Whiteley J, Wagner JS, Bushmakin A, et al. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause. 2013;20(5):518–524.
   PubMed Web of Science ®Google Scholar
• Assaf AR, Bushmakin AG, Joyce N, et al. The relative burden of menopausal and postmenopausal symptoms versus other major conditions: a retrospective analysis of the medical expenditure panel survey data. Am Health Drug Benefits. 2017;10(6):311–321.
   PubMed Web of Science ®Google Scholar
• Sheng Y, Carpenter JS, Elomba CD, et al. Review of menopausal palpitations measures. Womens Midlife Health. 2021;7(1):5.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Heinemann LA, DoMinh T, Strelow F, et al. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes. 2004;2(1):67.
   PubMedGoogle Scholar
• Greene JG. Constructing a standard climacteric scale. Maturitas. 1998;29(1):25–31.
   PubMed Web of Science ®Google Scholar
• Im EO. The Midlife Women's Symptom Index (MSI). Health Care Women Int. 2006;27(3):268–287.
   PubMedGoogle Scholar
• Holte A, Mikkelsen A. The menopausal syndrome: a factor analytic replication. Maturitas. 1991;13(3):193–203.
   PubMed Web of Science ®Google Scholar
• Hunter M. The south-east England longitudinal study of the climacteric and postmenopause. Maturitas. 1992;14(2):117–126.
   PubMed Web of Science ®Google Scholar
• Neugarten BL, Kraines RJ. "Menopausal symptoms" in women of various ages. Psychosom Med. 1965;27:266–273.
   PubMed Web of Science ®Google Scholar
• Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, Salamone L, Stellato R. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152(5):463–473.
   PubMed Web of Science ®Google Scholar
• Perz JM. Development of the menopause symptom list: a factor analytic study of menopause associated symptoms. Women Health. 1997;25(1):53–69.
   PubMed Web of Science ®Google Scholar
• Delaplaine RW, Bottomy JR, Blatt M, et al. Effective control of the surgical menopause by estradiol pellet implantation at the time of surgery. Surg Gynecol Obstet. 1952;94(3):323–333.
   PubMedGoogle Scholar
• Blatt MH, Wiesbader H, Kupperman HS. Vitamin E and climacteric syndrome; failure of effective control as measured by menopausal index. AMA Arch Intern Med. 1953;91(6):792–799.
   PubMedGoogle Scholar
• Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. J Am Med Assoc. 1959;171:1627–1637.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:14898.
   Google Scholar
• Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;22(11):1155–1172.
   PubMed Web of Science ®Google Scholar
• Anarte MT, Cuadros JL, Herrera J. Hormonal and psychological treatment: therapeutic alternative for menopausal women? Maturitas. 1998;29(3):203–213.
   PubMed Web of Science ®Google Scholar
• Bhattacharya SM, Jha A. Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause. Int J Gynaecol Obstet. 2010;110(3):213–216.
   PubMed Web of Science ®Google Scholar
• Carmignani LO, Pedro AO, Costa-Paiva LH, et al. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas. 2010;67(3):262–269.
   PubMed Web of Science ®Google Scholar
• Checa MA, Garrido A, Prat M, et al. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study. Maturitas. 2005;52(1):70–77.
   PubMed Web of Science ®Google Scholar
• Chittacharoen A, Domhardt R, Manonai J, et al. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy. J Med Assoc Thai. 2004;87(1):1–7.
   PubMedGoogle Scholar
• Elfituri A, Sherif F, Elmahaishi M, et al. Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women. Maturitas. 2005;52(1):52–59.
   PubMed Web of Science ®Google Scholar
• Kim HK, Jeon SH, Ryu KJ, et al. Comparison of the efficacy of tibolone and transdermal estrogen in treating menopausal symptoms in postmenopausal women. J Menopausal Med. 2019;25(3):123–129.
   PubMedGoogle Scholar
• Moyer AM, de Andrade M, Faubion SS, et al. SLCO1B1 genetic variation and hormone therapy in menopausal women. Menopause. 2018;25(8):877–882.
   PubMed Web of Science ®Google Scholar
• Polo-Kantola P, Erkkola R, Helenius H, et al. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol. 1998;178(5):1002–1009.
   PubMed Web of Science ®Google Scholar
• Pornel B. Efficacy and safety of Menorest in two positive-controlled studies. Eur J Obstet Gynecol Reprod Biol. 1996;64(Suppl):S35–S37.
   PubMedGoogle Scholar
• Takamatsu K, Ohta H, Makita K, et al. Effects of counseling on climacteric symptoms in Japanese postmenopausal women. J Obstet Gynaecol Res. 2001;27(3):133–140.
   PubMed Web of Science ®Google Scholar
• Ţiţ DM, Pallag A, Iovan C, et al. Somatic-vegetative symptoms evolution in postmenopausal women treated with phytoestrogens and hormone replacement therapy. Iran J Public Health. 2017;46(11):1528–1534.
   PubMed Web of Science ®Google Scholar
• Glaser R, York AE, Dimitrakakis C. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas. 2011;68(4):355–361.
   PubMed Web of Science ®Google Scholar
• Fluck E, File SE, Rymer J. Cognitive effects of 10 years of hormone-replacement therapy with tibolone. J Clin Psychopharmacol. 2002;22(1):62–67.
   PubMed Web of Science ®Google Scholar
• Nevinny-Stickel J. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients. Arch Gynecol. 1983;234(1):27–31.
   PubMedGoogle Scholar
• Callegari C, Ielmini M, Caselli I, et al. Paroxetine versus vortioxetine for depressive symptoms in postmenopausal transition: a preliminary study. Psychopharmacol Bull. 2019;49(1):28–43.
   PubMedGoogle Scholar
• Freeman MP, Cheng LJ, Moustafa D, et al. Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition. Ann Clin Psychiatry. 2017;29(4):249–257.
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Clayton AH, Bao W, et al. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women. J Womens Health (Larchmt). 2015;24(4):281–290.
   PubMed Web of Science ®Google Scholar
• Kujala SM, Pöyhönen-Alho M, Kaaja RJ. Effects of sympatholytic therapy on postmenopausal symptoms in hypertensive postmenopausal women. Climacteric. 2014;17(4):356–362.
   PubMed Web of Science ®Google Scholar
• Agosta C, Atlante M, Benvenuti C. Randomized controlled study on clinical efficacy of isoflavones plus Lactobacillus sporogenes, associated or not with a natural anxiolytic agent in menopause. Minerva Ginecol. 2011;63(1):11–17.
   PubMedGoogle Scholar
• Ahsan M, Mallick AK. The effect of soy isoflavones on the menopause rating scale scoring in perimenopausal and postmenopausal women: a pilot study. J Clin Diagn Res. 2017;11(9):FC13–FC16.
   PubMed Web of Science ®Google Scholar
• Auerbach L, Rakus J, Bauer C, et al. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial. Menopause. 2012;19(4):426–432.
   PubMed Web of Science ®Google Scholar
• Costa JG, Giolo JS, Mariano IM, et al. Combined exercise training reduces climacteric symptoms without the additive effects of isoflavone supplementation: a clinical, controlled, randomised, double-blind study. Nutr Health. 2017;23(4):271–279.
   PubMedGoogle Scholar
• Davinelli S, Scapagnini G, Marzatico F, et al. Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: a randomized, placebo-controlled study. Maturitas. 2017;96:77–83.
   PubMed Web of Science ®Google Scholar
• Hasper I, Ventskovskiy BM, Rettenberger R, et al. Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause. 2009;16(1):117–131.
   PubMed Web of Science ®Google Scholar
• Heger M, Ventskovskiy BM, Borzenko I, et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial. Menopause. 2006;13(5):744–759.
   PubMed Web of Science ®Google Scholar
• Kaszkin-Bettag M, Ventskovskiy BM, Solskyy S, et al. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms. Altern Ther Health Med. 2009;15(1):24–34.
   PubMed Web of Science ®Google Scholar
• Bommer S, Klein P, Suter A. First time proof of sage's tolerability and efficacy in menopausal women with hot flushes. Adv Therapy. 2011;28(6):490–500.
   PubMed Web of Science ®Google Scholar
• Dadfar F, Bamdad K. The effect of Saliva officinalis extract on the menopausal symptoms in postmenopausal women: an RCT. Int J Reprod Biomed (Yazd). 2019;17(4):287–292.
   Web of Science ®Google Scholar
• Zeidabadi A, Yazdanpanahi Z, Dabbaghmanesh MH, et al. The effect of Salvia officinalis extract on symptoms of flushing, night sweat, sleep disorders, and score of forgetfulness in postmenopausal women. J Family Med Prim Care. 2020;9(2):1086–1092.
   PubMedGoogle Scholar
• Fatima L, Sultana A. Efficacy of Tribulus terrestris L. (fruits) in menopausal transition symptoms: a randomized placebo controlled study. Adv Integr Med. 2017;4(2):56–65.
   Web of Science ®Google Scholar
• Modi MB, Donga SB, Dei L. Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome. Ayu. 2012;33(4):511–516.
   PubMedGoogle Scholar
• Nayak C, Singh V, Singh K, et al. Management of distress during climacteric years by homeopathic therapy. J Altern Complement Med. 2011;17(11):1037–1042.
   PubMed Web of Science ®Google Scholar
• Park JY, Kim KH. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric. 2016;19(6):574–580.
   PubMed Web of Science ®Google Scholar
• Alder J, Besken KE, Armbruster U, et al. Cognitive-behavioural group intervention for climacteric syndrome. Psychother Psychosom. 2006;75(5):298–303.
   PubMed Web of Science ®Google Scholar
• Qian L, Wang B, Niu J, et al. Assessment of the clinical effect of Chinese medicine therapy combined with psychological intervention for treatment of patients of peri-menopausal syndrome complicated with hyperlipidemia. Chin J Integr Med. 2010;16(2):124–130.
   PubMed Web of Science ®Google Scholar
• Kung YY, Yang CC, Chiu JH, et al. The relationship of subjective sleep quality and cardiac autonomic nervous system in postmenopausal women with insomnia under auricular acupressure. Menopause. 2011;18(6):638–645.
   PubMed Web of Science ®Google Scholar
• Formoso G, Perrone E, Maltoni S, et al. Short‐term and long‐term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev. 2016;10(10):CD008536.
   PubMedGoogle Scholar
• Orleans RJ, Li L, Kim M-J, et al. FDA approval of paroxetine for menopausal hot flushes. N Engl J Med. 2014;370(19):1777–1779.
   PubMed Web of Science ®Google Scholar
• Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal symptoms. Fertil Steril. 2014;101(4):905–915.
   PubMed Web of Science ®Google Scholar
• Unfer V, Casini ML, Costabile L, et al. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2004;82(1):145–148.
   PubMed Web of Science ®Google Scholar
• Chang J-L, Montalto MB, Heger PW, et al. Rheum rhaponticum extract (ERr 731): postmarketing data on safety surveillance and consumer complaints. Integr Med (Encinitas). 2016;15(3):34–39.
   PubMedGoogle Scholar
• Lopresti AL. Salvia (sage): a review of its potential cognitive-enhancing and protective effects. Drugs R D. 2017;17(1):53–64.
   PubMed Web of Science ®Google Scholar
• Bellanger RA, Seeger CM, Smith HE. Safety of complementary and alternative medicine treatments and practices. In: Ray SD, editor. Side effects of drugs annual. Cambridge (MA): Elsevier; 2019. p. 559–571.
   Google Scholar
• Haidich AB. Meta-analysis in medical research. Hippokratia. 2010;14(Suppl 1):29–37.
   PubMed Web of Science ®Google Scholar
• Marston HR, Hadley R, Banks D, et al. Mobile self-monitoring ecg devices to diagnose arrhythmia that coincide with palpitations: a scoping review. Healthcare (Basel). 2019;7(3):96.
   Google Scholar
• Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary: a Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias) Developed in collaboration with NASPE–Heart Rhythm Society. Eur Heart J. 2003;24(20):1857–1897.
   Google Scholar
• Carranza-Lira S, Cortés-Fuentes E. Modification of vasomotor symptoms after various treatment modalities in the postmenopause. Int J Gynecol Obstet. 2001;73(2):169–171.
   PubMed Web of Science ®Google Scholar